Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy
HCE Buyck, PD Griffiths, VC Emery - Journal of clinical virology, 2010 - Elsevier
BACKGROUND: Cytomegalovirus (HCMV) remains an important infection following stem
cell transplantation (SCT) and is managed via pre-emptive therapy. In some patients HCMV
loads continue to increase after therapy and they experience multiple episodes of
replication. OBJECTIVES: To identify the risk factors associated with failure to immediately
control HCMV replication after antiviral therapy and for recurrence of replication. STUDY
DESIGN: Replication kinetics of human cytomegalovirus (HCMV) were studied a cohort of …
cell transplantation (SCT) and is managed via pre-emptive therapy. In some patients HCMV
loads continue to increase after therapy and they experience multiple episodes of
replication. OBJECTIVES: To identify the risk factors associated with failure to immediately
control HCMV replication after antiviral therapy and for recurrence of replication. STUDY
DESIGN: Replication kinetics of human cytomegalovirus (HCMV) were studied a cohort of …